Glomerulonephritis

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

TESTING -ON Post-Trial ObservatioNal Cohort Study

Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study

ANTI-SARS-CoV-2 SEROCONVERSIO IN IMMUNE-MEDIATED KIDNEY DISEASES

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Bortezomib for Treating Glomerular Diseases

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria